Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-25 @ 2:45 AM
NCT ID:
NCT02638233
Eligibility Criteria:
Inclusion Criteria:
* Chronic genotype 1 HCV infection
* Fibrosis F0-F3 (i.e. non-cirrhotic confirmed by Fibroscan \<12.5kPa)
* Stable opiate substitution therapy
* Regular visits at the low threshold facility during the last month
Exclusion Criteria:
* Lack or unwillingness of safe contraception, pregnancy
* Liver cirrhosis (Fibroscan ≥12.5kPa)
* Coinfection with HBV (Hepatitis B Virus) or HIV (coinfection with HIV is excluded only because there are very few coinfected patients under care at the "Ambulatorium Suchthilfe Wien" and hence this subpopulation would be very small)
* Severe comorbidities resulting in a life expectancy of less than five years
* HCC (Hepatocellular carcinoma)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02638233
Study Brief:
Protocol Section:
NCT02638233